Baiyunshan Cephalexin Capsules Receive Macau Drug Registration Certificate

Regulation
โดย Jiemian·Read original
Summary · why it matters

Baiyunshan announced that its branch, Baiyunshan Pharmaceutical General Factory, received a Drug Registration Certificate issued by the Macau Pharmaceutical Administration Bureau on July 20, 2026, for cephalexin capsules. The product is a prescription drug indicated for respiratory tract infections, urinary tract infections, and skin and soft tissue infections caused by susceptible bacteria. Baiyunshan Pharmaceutical General Factory has authorized GPHL International Macau to distribute the product in Macau.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 1

广药国际（澳门）Private▲ Positive
Demandrelevance

Authorized as distributor for Baiyunshan's cephalexin capsules in Macau, gaining product to sell.

© 2026 MarketDXNews